Key result
Guanadrel sulfate matches guanethidine or methyldopa for BP reduction with fewer CNS side effects.
Why the study?
Guanadrel sulfate is a postganglionic sympathetic inhibitor with pharmacokinetic differences from guanethidine, and its efficacy and side effect profile in mild to moderate hypertension require evaluation.
Does guanadrel sulfate reduce blood pressure in persons with mild to moderately severe hypertension?
Does guanadrel sulfate reduce blood pressure in persons with mild to moderately severe hypertension?
Answers are grounded in this paper and cite their sources.
Guanadrel sulfate is an effective step 2 antihypertensive agent that serves as a reasonable alternative to guanethidine or methyldopa with potentially fewer central nervous system side effects.
Guanadrel sulfate is structurally and pharmacologically similar to guanethidine but has different pharmacokinetic properties. The drug produces peripheral postganglionic sympathetic blockade as a consequence of interference with neuronal release of norepinephrine and displacement of norepinephrine from storage vesicles. Animal studies using large multiples of human antihypertensive doses suggest a low order of human toxicity. Clinical studies have failed to reveal any major effect on hematologic, hepatic or renal function. The effect on serum lipids and plasma renin is unknown. The drug is well absorbed after oral administration. Peak plasma levels in humans occur 1.5–2 hours after a administration. Protein binding is less than 20%. Data from animal studies and clinical trials demonstrating a lack of central nervous system side effects indicate that little if any drug enters the central nervous system. The drug is partially metabolized by the liver, but nearly 50% of an orally administered dose appears unchanged in the urine. The mean elimination half‐life is approximately 12 hours. The onset of antihypertensive action after oral administration of guanadrel to humans is 30–120 minutes (mean 77 minutes). The offset of drug action after a single oral dose ranges between 4–14 hours (mean 9 hours). The hypotensive response to guanadrel in hypertensive subjects is the result of a decline in systemic vascular resistance with an impairment of the normal sympathetic reflexes in the erect position. Guanadrel causes a reduction in renal blood flow and glomerular filtration rate in the erect position. Open label clinical trials of antihypertensive efficacy indicate that guanadrel is effective in 60 and 70% of patients in the supine and erect positions, respectively. In comparative clinical trials, guanadrel appears to be as effective as guanethidine or methyldopa in reducing blood pressure in persons with mild to moderately severe hypertension; mean doses ranged from 56–162 mg/day. In other studies, investigators have used doses of 5–600 mg daily. The maximum recommended dosage is 400 mg/day. Side effects reported with guanadrel administration are those that would be predicted for a postganglionic sympathetic inhibitor that does not enter the central nervous system. Sexual dysfunction, orthostatic dizziness and diarrhea occur with the drug but do not seem to be as frequent or as severe as with guanethidine administration. In a comparison of guanadrel to methyldopa, methyldopa caused more complaints of drowsiness, and drowsiness scores of methyldopa patients remained higher than those of guanadrel patients even after two years of therapy. The drug has received approval as a step 2 antihypertensive agent in the United States. The available data suggest that it will serve as a reasonable alternative to other step 2 antihypertensives.
No takes yet. Share an insight, caveat, or question.
Palmer et al. (1983) conducted a review in Mild to moderate hypertension. Guanadrel sulfate vs. Guanethidine or methyldopa was evaluated on Blood pressure reduction. Guanadrel sulfate is as effective as guanethidine or methyldopa in reducing blood pressure for mild to moderate hypertension, with fewer central nervous system side effects such as drowsiness.
Synapse has enriched 10 related papers. Consider them for comparative context: